|
Gandhi, Rajesh T, Tashima, Karen T, Smeaton, Laura M, Vu, Vincent, Ritz, Justin, Andrade, Adriana, Eron, Joseph J, Hogg, Evelyn, Fichtenbaum, Carl J.
"Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS)." The Journal of Infectious Diseases, vol. 221, no. 9, 2019, pp. 1407-1415.
|
|
Seider, Talia R., Gongvatana, Assawin, Woods, Adam J., Chen, Huaihou, Porges, Eric C., Cummings, Tiffany, Correia, Stephen, Tashima, Karen, Cohen, Ronald A.
"Age exacerbates HIV-associated white matter abnormalities." Journal of NeuroVirology, vol. 22, no. 2, 2015, pp. 201-212.
|
|
Glavis-Bloom, Justin, Vasher, Scott, Marmor, Meghan, Fine, Antonella B., Chan, Philip A., Tashima, Karen T., Lonks, John R., Kojic, Erna M.
"Candida and cardiovascular implantable electronic devices: a case of lead and native aortic valve endocarditis and literature review." Mycoses, vol. 58, no. 11, 2015, pp. 637-641.
|
|
Young, Benjamin, Squires, Kathleen E., Tashima, Karen, Henry, Keith, Schneider, Stefan, LaMarca, Anthony, Zhao, Henry H., Ross, Lisa L., Shaefer, Mark S.
"Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine." HIV Clinical Trials, vol. 16, no. 4, 2015, pp. 125-129.
|
|
Clark, Uraina S., Walker, Keenan A., Cohen, Ronald A., Devlin, Kathryn N., Folkers, Anna M., Pina, Matthew J., Tashima, Karen T.
"Facial emotion recognition impairments are associated with brain volume abnormalities in individuals with HIV." Neuropsychologia, vol. 70, 2015, pp. 263-271.
|
|
Stanton, Cassandra A., Papandonatos, George D., Shuter, Jonathan, Bicki, Alexandra, Lloyd-Richardson, Elizabeth E., de Dios, Marcel A., Morrow, Kathleen M., Makgoeng, Solomon B., Tashima, Karen T., Niaura, Raymond S.
"Outcomes of a Tailored Intervention for Cigarette Smoking Cessation Among Latinos Living With HIV/AIDS." Nicotine & Tobacco Research, vol. 17, no. 8, 2015, pp. 975-82.
|
|
Kwara A, Cao L, Yang H, Poethke P, Kurpewski J, Tashima KT, Mahjoub BD, Court MH, Peloquin CA.
"Factors associated with variability in rifampin plasma pharmacokinetics and the relationship between rifampin concentrations and induction of efavirenz clearance." Pharmacotherapy, vol. 34, no. 3, 2014, pp. 265-71.
|
|
Caldwell JZ, Gongvatana A, Navia BA, Sweet LH, Tashima K, Ding M, Cohen RA.
"Neural dysregulation during a working memory task in human immunodeficiency virus-seropositive and hepatitis C coinfected individuals." Journal of NeuroVirology, vol. 20, no. 4, 2014, pp. 398-411.
|
|
Seider TR, Luo X, Gongvatana A, Devlin KN, de la Monte SM, Chasman JD, Yan P, Tashima KT, Navia B, Cohen RA.
"Verbal memory declines more rapidly with age in HIV infected versus uninfected adults." Journal of Clinical and Experimental Neuropsychology, vol. 36, no. 4, 2014, pp. 356-67.
|
|
Leeper S, Fillion K, Gillani FS, Rana A, Tashima K, Ross H.
"Decade of HIV in Rhode Island: demographic and clinical characteristics of patients diagnosed in 2001 and 2010." Rhode Island medical journal (2013), vol. 96, no. 2, 2013, pp. 35-40.
|
|
Westbrook ML, Garg S, Chapman S, Cu-Uvin S, Tashima KT, Taylor LE.
"Hepatocellular carcinoma in HIV-infected women: two case reports." Rhode Island medical journal (2013), vol. 96, no. 1, 2013, pp. 21-4.
|
|
Correia S, Cohen R, Gongvatana A, Ross S, Olchowski J, Devlin K, Tashima K, Navia B, Delamonte S.
"Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV." Journal of neuroimmunology, vol. 265, no. 1-2, 2013, pp. 117-23.
|
|
Zachary D, Gillani FS, Najfi N, Casarella R, Tashima K.
"Cardiovascular health of HIV-infected African-American women at the Miriam Hospital Immunology Center in Providence, RI." Medicine and health, Rhode Island, vol. 95, no. 6, 2012, pp. 179-82.
|
|
Clark, Uraina S., Cohen, Ronald A., Sweet, Lawrence H., Gongvatana, Assawin, Devlin, Kathryn N., Hana, George N., Westbrook, Michelle L., Mulligan, Richard C., Jerskey, Beth A., White, Tara L., Navia, Bradford, Tashima, Karen T.
"Effects of HIV and early life stress on amygdala morphometry and neurocognitive function." Journal of the International Neuropsychological Society, vol. 18, no. 4, 2012, pp. 657-668.
|
|
Devlin KN, Gongvatana A, Clark US, Chasman JD, Westbrook ML, Tashima KT, Navia B, Cohen RA.
"Neurocognitive effects of HIV, hepatitis C, and substance use history." Journal of the International Neuropsychological Society, vol. 18, no. 1, 2012, pp. 68-78.
|
|
Hogan CM, Degruttola V, Sun X, Fiscus SA, Del Rio C, Hare CB, Markowitz M, Connick E, Macatangay B, Tashima KT, Kallungal B, Camp R, Morton T, Daar ES, Little S, A5217 Study Team.
"The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals." The Journal of Infectious Diseases, vol. 205, no. 1, 2012, pp. 87-96.
|
|
Sax PE, Tierney C, Collier AC, Daar ES, Mollan K, Budhathoki C, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Ha B, Woodward WC, Feinberg J, Tashima K, Murphy RL, Fischl MA, AIDS Clinical Trials Group Study A5202 Team.
"Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results." The Journal of Infectious Diseases, vol. 204, no. 8, 2011, pp. 1191-201.
|
|
Shikuma CM, Ribaudo HJ, Zheng Y, Gulick RM, Meyer WA, Tashima KT, Bastow B, Kuritzkes DR, Glesby MJ, AIDS Clinical Trials Group A5095 Study Team.
"Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals." AIDS Research and Human Retroviruses, vol. 27, no. 5, 2011, pp. 461-8.
|
|
Gongvatana A, Cohen RA, Correia S, Devlin KN, Miles J, Kang H, Ombao H, Navia B, Laidlaw DH, Tashima KT.
"Clinical contributors to cerebral white matter integrity in HIV-infected individuals." Journal of NeuroVirology, vol. 17, no. 5, 2011, pp. 477-86.
|
|
Zachary D, Chapin K, Binns L, Tashima K.
"Cutaneous mucormycosis complicating a polymicrobial wound infection following a dog bite." Case Reports in Infectious Diseases, vol. 2011, 2011, pp. 348046.
|
|
Taylor LE, Holubar M, Wu K, Bosch RJ, Wyles DL, Davis JA, Mayer KH, Sherman KE, Tashima KT.
"Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials." Clinical Infectious Diseases, vol. 52, no. 6, 2011, pp. 812-8.
|
|
Kwara A, Tashima KT, Dumond JB, Poethke P, Kurpewski J, Kashuba AD, Court MH, Greenblatt DJ.
"Modest but variable effect of rifampin on steady-state plasma pharmacokinetics of efavirenz in healthy African-American and Caucasian volunteers." Antimicrobial Agents and Chemotherapy, vol. 55, no. 7, 2011, pp. 3527-33.
|
|
Overton ET, Kauwe JS, Paul R, Tashima K, Tate DF, Patel P, Carpenter CC, Patty D, Brooks JT, Clifford DB.
"Performances on the CogState and standard neuropsychological batteries among HIV patients without dementia." AIDS and Behavior, vol. 15, no. 8, 2011, pp. 1902-9.
|
|
Cohen RA, de la Monte S, Gongvatana A, Ombao H, Gonzalez B, Devlin KN, Navia B, Tashima KT.
"Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning." Journal of neuroimmunology, vol. 233, no. 1-2, 2011, pp. 204-10.
|
|
Tate DF, Delong A, McCaffrey DE, Kertesz K, Paul RH, Conley J, Russell T, Coop K, Gillani F, Flanigan T, Tashima K, Hogan JW.
"Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients." Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, vol. 26, no. 7, 2011, pp. 614-23.
|
|
Chan PA, Tashima K, Cartwright CP, Gillani FS, Mintz O, Zeller K, Kantor R.
"Short communication: Transmitted drug resistance and molecular epidemiology in antiretroviral naive HIV type 1-infected patients in Rhode Island." AIDS Research and Human Retroviruses, vol. 27, no. 3, 2011, pp. 275-81.
|
|
Clark US, Cohen RA, Westbrook ML, Devlin KN, Tashima KT.
"Facial emotion recognition impairments in individuals with HIV." Journal of the International Neuropsychological Society, vol. 16, no. 6, 2010, pp. 1127-37.
|
|
Tate DF, Conley J, Paul RH, Coop K, Zhang S, Zhou W, Laidlaw DH, Taylor LE, Flanigan T, Navia B, Cohen R, Tashima K.
"Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients." Brain Imaging and Behavior, vol. 4, no. 1, 2010, pp. 68-79.
|
|
Tsibris AM, Paredes R, Chadburn A, Su Z, Henrich TJ, Krambrink A, Hughes MD, Aberg JA, Currier JS, Tashima K, Godfrey C, Greaves W, Flexner C, Skolnik PR, Wilkin TJ, Gulick RM, Kuritzkes DR.
"Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211." Clinical Infectious Diseases, vol. 48, no. 5, 2009, pp. 642-9.
|
|
Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Shadel WG, Stein M, Tashima K, Flanigan T, Morrow K, Neighbors C, Niaura R.
"Motivation and patch treatment for HIV+ smokers: a randomized controlled trial." Addiction, vol. 104, no. 11, 2009, pp. 1891-900.
|
|
Tebas P, Zhang J, Hafner R, Tashima K, Shevitz A, Yarasheski K, Berzins B, Owens S, Forand J, Evans S, Murphy R.
"Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110." Journal of Antimicrobial Chemotherapy, vol. 63, no. 5, 2009, pp. 998-1005.
|
|
Zachary D, Rosas D, Chan F, Tashima K.
"X marks the spot: cosmetic surgery gone awry." Medicine and health, Rhode Island, vol. 92, no. 12, 2009, pp. 416-7.
|
|
Castillo J, Hansen C, Mega A, Tashima K.
"AIDS-related lymphomas: the Rhode Island experience." Medicine and health, Rhode Island, vol. 91, no. 11, 2008, pp. 332-4.
|
|
Tashima K, Staszewski S, Nelson M, Rachlis A, Skiest D, Stryker R, Bessen L, Overfield S, Ruiz N, Wirtz V.
"Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection." AIDS, vol. 22, no. 2, 2008, pp. 275-9.
|
|
Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Betancourt RM, Stein M, Tashima K, Morrow K, Niaura R.
"HIV-positive smokers considering quitting: differences by race/ethnicity." Am J Hlth Behav, vol. 32, no. 1, 2008, pp. 3-15.
|
|
Kawana M, Starr RS, Tashima KT, Treaba DO, Flanigan TP.
"Spontaneous perforation of the terminal ileum in an AIDS patient on highly active antiretroviral therapy with disseminated non-tuberculous mycobacterial infection." International Journal of Infectious Diseases, vol. 12, no. 6, 2008, pp. 603-6.
|
|
Riddler SA, Jiang H, Tenorio A, Huang H, Kuritzkes DR, Acosta EP, Landay A, Bastow B, Haas DW, Tashima KT, Jain MK, Deeks SG, Bartlett JA.
"A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115." Antiviral therapy, vol. 12, no. 4, 2007, pp. 531-41.
|
|
Shikuma CM, Yang Y, Glesby MJ, Meyer WA 3rd, Tashima KT, Ribaudo HJ, Webb N, Bastow B, Kuritzkes DR, Gulick RM.
"Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095)." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 44, no. 5, 2007, pp. 540-50.
|
|
Kumar PN, Rodriguez-French A, Thompson MA, Tashima KT, Averitt D, Wannamaker PG, Williams VC, Shaefer MS, Pakes GE, Pappa KA, ESS40002 Study Team.
"A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity." HIV medicine, vol. 7, no. 2, 2006, pp. 85-98.
|
|
Lai AR, Tashima KT, Taylor LE.
"Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virus." AIDS Patient Care and STDs, vol. 20, no. 10, 2006, pp. 678-92.
|
|
Tashima KT, Mitty JA.
"Once-daily therapies for the treatment of HIV infection." Current HIV/AIDS Reports, vol. 3, no. 2, 2006, pp. 86-92.
|
|
Ribaudo HJ, Haas DW, Tierney C, Kim RB, Wilkinson GR, Gulick RM, Clifford DB, Marzolini C, Fletcher CV, Tashima KT, Kuritzkes DR, Acosta EP, Adult AIDS Clinical Trials Group Study.
"Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study." Clinical Infectious Diseases, vol. 42, no. 3, 2006, pp. 401-7.
|
|
Martin TM, Morse GD, Kurpewski J, Difrancesco R, Caliendo AM, Flanigan TP, Tashima KT.
"Plasma and cerebrospinal pharmacokinetics and pharmacodynamics in subjects taking lopinavir/ritonavir." AIDS, vol. 20, no. 7, 2006, pp. 1085-7.
|
|
Swindells S, Cohen CJ, Berger DS, Tashima KT, Liao Q, Pobiner BF, Snidow JW, Pakes GE, Hernandez JE, NZTA4008 Study Team.
"Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens." BMC infectious diseases, vol. 5, 2005, pp. 23.
|
|
Paul R, Flanigan TP, Tashima K, Cohen R, Lawrence J, Alt E, Tate D, Ritchie C, Hinkin C.
"Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus." The Journal of neuropsychiatry and clinical neurosciences, vol. 17, no. 1, 2005, pp. 114-8.
|
|
Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA.
"Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America." Clinical Infectious Diseases, vol. 40, no. 11, 2005, pp. 1559-85.
|
|
Clifford DB, Evans S, Yang Y, Acosta EP, Goodkin K, Tashima K, Simpson D, Dorfman D, Ribaudo H, Gulick RM.
"Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals." Annals of Internal Medicine, vol. 143, no. 10, 2005, pp. 714-21.
|
|
Taylor LE, Rich JD, Tashima KT.
"Peginterferon plus ribavirin for hepatitis C in HIV-infected patients." New England Journal of Medicine, vol. 351, no. 22, 2004, pp. 2340-2; author reply 2340-2.
|
|
Bausserman LL, Tashima KT, DiSpigno M, Maceroni D, Carpenter CC.
"Racial differences in serum lipids in HIV+ women treated with protease inhibitor regimens." HIV Clinical Trials, vol. 5, no. 6, 2004, pp. 399-405.
|
|
Shah P, Paul R, Gold R, Tashima K, Flanigan T.
"Treating HIV encephalopathy with antiretroviral therapy: a clinical case demonstrating the success of HAART." Clinical Infectious Diseases, vol. 39, no. 10, 2004, pp. 1545-7.
|
|
Tashima KT, Carpenter CC.
"Fusion inhibition--a major but costly step forward in the treatment of HIV-1." New England Journal of Medicine, vol. 348, no. 22, 2003, pp. 2249-50.
|
|
Dubé MP, Stein JH, Aberg JA, Fichtenbaum CJ, Gerber JG, Tashima KT, Henry WK, Currier JS, Sprecher D, Glesby MJ, Adult AIDS Clinical Trials Group Cardiovascular Subcommittee, HIV Medical Association of the Infectious Disease Society of America.
"Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group." Clinical Infectious Diseases, vol. 37, no. 5, 2003, pp. 613-27.
|
|
Tashima KT, Alt EN, Harwell JI, Fiebich-Perez DK, Flanigan TP.
"Internet sex-seeking leads to acute HIV infection: a report of two cases." International journal of STD & AIDS, vol. 14, no. 4, 2003, pp. 285-6.
|
|
Tashima KT, Bausserman L, Alt EN, Aznar E, Flanigan TP.
"Lipid changes in patients initiating efavirenz- and indinavir-based antiretroviral regimens." HIV Clinical Trials, vol. 4, no. 1, 2003, pp. 29-36.
|
|
Tashima K, Weiss M.
"Prevention of HIV transmission after health care worker occupational exposure." Medicine and health, Rhode Island, vol. 86, no. 6, 2003, pp. 172-4.
|
|
Gardner LI, Klein RS, Szczech LA, Phelps RM, Tashima K, Rompalo AM, Schuman P, Sadek RF, Tong TC, Greenberg A, Holmberg SD, HIV Epidemiology Research Study Group.
"Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 34, no. 3, 2003, pp. 320-30.
|
|
Tate D, Paul RH, Flanigan TP, Tashima K, Nash J, Adair C, Boland R, Cohen RA.
"The impact of apathy and depression on quality of life in patients infected with HIV." AIDS Patient Care and STDs, vol. 17, no. 3, 2003, pp. 115-20.
|
|
Tashima KT, Flanigan TP, Kurpewski J, Melanson SM, Skolnik PR.
"Discordant Human Immunodeficiency Virus Type 1 drug resistance mutations, including K103N, observed in cerebrospinal fluid and plasma." Clinical Infectious Diseases, vol. 35, no. 1, 2002, pp. 82-3.
|
|
DiRienzo AG, van Der Horst C, Finkelstein DM, Frame P, Bozzette SA, Tashima KT.
"Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection." AIDS Research and Human Retroviruses, vol. 18, no. 2, 2002, pp. 89-94.
|
|
Taylor LE, Costello T, Alt E, Yates G, Tashima K.
"Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals." AIDS, vol. 16, no. 12, 2002, pp. 1700-1.
|
|
Paul R, Cohen R, Navia B, Tashima K.
"Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1." Neuroscience & Biobehavioral Reviews, vol. 26, no. 3, 2002, pp. 353-9.
|
|
Kirkland LR, Fischl MA, Tashima KT, Paar D, Gensler T, Graham NM, Gao H, Rosenzweig JR, McClernon DR, Pittman G, Hessenthaler SM, Hernandez JE, NZTA4007 Study Team.
"Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment." Clinical Infectious Diseases, vol. 34, no. 4, 2002, pp. 511-8.
|
|
Tashima KT, Hogan JW, Gardner LI, Korkontzelou C, Schoenbaum EE, Schuman P, Rompalo A, Carpenter CC.
"A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use." Clinical Infectious Diseases, vol. 33, no. 12, 2001, pp. 2055-60.
|
|
Flanigan T, Tashima KT.
"Diagnosis of acute HIV infection: it's time to get moving!." Annals of Internal Medicine, vol. 134, no. 1, 2001, pp. 75-7.
|
|
Jonsén E, Suhr OB, Tashima K, Athlin E.
"Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life." Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, vol. 8, no. 1, 2001, pp. 52-7.
|
|
Kazanjian P, Tashima K, Hollander T, Kaul D.
"Effect of prior nucleoside use on the two-year virological response to an initial protease inhibitor regimen in HIV-infected patients." HIV Clinical Trials, vol. 2, no. 3, 2001, pp. 213-8.
|
|
Williams AB, Yu C, Tashima K, Burgess J, Danvers K.
"Evaluation of two self-care treatments for prevention of vaginal candidiasis in women with HIV." Journal of the Association of Nurses in AIDS Care, vol. 12, no. 4, 2001, pp. 51-7.
|
|
Cohen RA, Boland R, Paul R, Tashima KT, Schoenbaum EE, Celentano DD, Schuman P, Smith DK, Carpenter CC.
"Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women." AIDS, vol. 15, no. 3, 2001, pp. 341-5.
|
|
Alonso P, Tashima KT, Goldstein IJ.
"Photo quiz. Disseminated Rhodocuccus equi infection." Clinical Infectious Diseases, vol. 32, no. 6, 2001, pp. 929, 970-1.
|
|
Mahajan AP, Tashima KT, Bausserman LL, Flynn MM, Carpenter CC.
"Plateau in body habitus changes and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy: a 3.5-year study." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 28, no. 4, 2001, pp. 332-5.
|
|
Tashima KT, Flanigan TP.
"Antiretroviral therapy in the year 2000." Infectious disease clinics of North America, vol. 14, no. 4, 2000, pp. 827-49.
|
|
Farley JL, Mitty JA, Lally MA, Burzynski JN, Tashima K, Rich JD, Cu-Uvin S, Spaulding A, Normandie L, Snead M, Flanigan TP.
"Comprehensive medical care among HIV-positive incarcerated women: the Rhode Island experience." Journal of Women's Health and Gender Based Medicine, vol. 9, no. 1, 2000, pp. 51-6.
|
|
Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB.
"Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now." Clinical Infectious Diseases, vol. 31, no. 3, 2000, pp. 808-12.
|
|
Tashima KT, Fiore TC.
"Sustained responses to dual nucleoside therapy in women." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 25, no. 4, 2000, pp. 371-2.
|
|
Ahmad M, Tashima KT, Caliendo AM, Flanigan TP.
"Cerebrospinal fluid and plasma HIV-1 RNA stability at 4 degrees C." AIDS, vol. 13, no. 10, 1999, pp. 1281-2.
|
|
Tashima KT, Caliendo AM, Ahmad M, Gormley JM, Fiske WD, Brennan JM, Flanigan TP.
"Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy." The Journal of Infectious Diseases, vol. 180, no. 3, 1999, pp. 862-4.
|
|
Dong KL, Bausserman LL, Flynn MM, Dickinson BP, Flanigan TP, Mileno MD, Tashima KT, Carpenter CC.
"Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART)." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 21, no. 2, 1999, pp. 107-13.
|
|
Staszewski S, Morales-Ramirez J, Tashima KT, Rachlis A, Skiest D, Stanford J, Stryker R, Johnson P, Labriola DF, Farina D, Manion DJ, Ruiz NM.
"Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team." New England Journal of Medicine, vol. 341, no. 25, 1999, pp. 1865-73.
|
|
Nakamura M, Yamashita T, Ando Y, Hamidi Asl K, Tashima K, Ohlsson P, Kususe Y, Benson MD.
"Identification of a new transthyretin variant (Ile49) in familial amyloidotic polyneuropathy using electrospray ionization mass spectrometry and nonisotopic RNase cleavage assay." Human heredity, vol. 49, no. 4, 1999, pp. 186-9.
|
|
Chodock R, Mylonakis E, Shemin D, Runarsdottir V, Yodice P, Renzi R, Tashima K, Towe C, Rich JD.
"Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis--role of haemodialysis treatment." Nephrol. Dial. Transplant., vol. 14, no. 10, 1999, pp. 2484-6.
|
|
Mylonakis E, Merriman NA, Rich JD, Flanigan TP, Walters BC, Tashima KT, Mileno MD, van der Horst CM.
"Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis." Diagnostic microbiology and infectious disease, vol. 34, no. 2, 1999, pp. 111-4.
|
|
Tashima KT.
"Cerebrospinal fluid levels of antiretroviral medications: abstract and commentary." JAMA, vol. 280, no. 10, 1998, pp. 879-80.
|
|
Williams AB, Andrews S, Tashima K, Mezger J, Yu C.
"Factors associated with vaginal yeast infections in HIV-positive women." Journal of the Association of Nurses in AIDS Care, vol. 9, no. 5, 1998, pp. 47-52.
|
|
Dickinson BP, Mitty JA, Mylonakis E, Rich JD, Merriman NA, Tashima KT, Carpenter CC, Flanigan TP.
"Predictors of undetectable HIV plasma viral load in 250 HIV-positive women receiving care." AIDS, vol. 12, no. 15, 1998, pp. 2075-6.
|
|
Mylonakis E, Koutkia P, Rich JD, Tashima KT, Fiore TC, Flanigan T, Carpenter CC.
"Substance abuse is responsible for most pre-AIDS deaths among women with HIV infection in Providence, Rhode Island, USA." AIDS, vol. 12, no. 8, 1998, pp. 958-9.
|
|
Tashima KT, Horowitz JD, Rosen S.
"Indinavir nephropathy." New England Journal of Medicine, vol. 336, no. 2, 1997, pp. 138-40.
|
|
Rich JD, Ramratnam B, Chiang M, Tashima KT.
"Management of indinavir associated nephrolithiasis." The Journal of Urology, vol. 158, no. 6, 1997, pp. 2228.
|
|
Carroll PA, Tashima KT, Rogers MB, DiRita VJ, Calderwood SB.
"Phase variation in tcpH modulates expression of the ToxR regulon in Vibrio cholerae." Molecular Microbiology, vol. 25, no. 6, 1997, pp. 1099-111.
|
|
Tashima KT, Carroll PA, Rogers MB, Calderwood SB.
"Relative importance of three iron-regulated outer membrane proteins for in vivo growth of Vibrio cholerae." Infection and Immunity, vol. 64, no. 5, 1996, pp. 1756-61.
|
|
Flanigan TP, Uvin SC, Rich JD, Mileno MD, Vigilante K, Tashima K.
"Update of HIV and AIDS in North America." Medicine and health, Rhode Island, vol. 79, no. 5, 1996, pp. 180-7.
|
